In this issue:
- Pregnancy after breast cancer in BRCA carriers
- Postoperative radiotherapy omission in early breast cancer
- Neoadjuvant sacituzumab govitecan for localised triple negative breast cancer
- Third-line treatment for metastatic triple-negative breast cancer
- Sacituzumab govitecan in HR-positive and HER2-negative metastatic breast cancer
- Adherence to cancer prevention recommendations and risk of lifestyle-related cancers
- Analysis of US breast cancer mortality 1975 to 2019
- Ten-year follow-up of women at high risk of familial breast and ovarian cancer
- Patient decision-making for mastectomy alone or breast reconstruction
- Patient determinants of breast cancer treatment
Please login below to download this issue (PDF)